Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data.
Bayesian inference
SARS-CoV-2 variants
contact tracing
generation time
incubation period
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
16 12 2022
16 12 2022
Historique:
pubmed:
17
12
2022
medline:
10
1
2023
entrez:
16
12
2022
Statut:
epublish
Résumé
Quantitative information on epidemiological quantities such as the incubation period and generation time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants is scarce. We analysed a dataset collected during contact tracing activities in the province of Reggio Emilia, Italy, throughout 2021. We determined the distributions of the incubation period for the Alpha and Delta variants using information on negative polymerase chain reaction tests and the date of last exposure from 282 symptomatic cases. We estimated the distributions of the intrinsic generation time using a Bayesian inference approach applied to 9724 SARS-CoV-2 cases clustered in 3545 households where at least one secondary case was recorded. We estimated a mean incubation period of 4.9 days (95% credible intervals, CrI, 4.4-5.4) for Alpha and 4.5 days (95% CrI 4.0-5.0) for Delta. The intrinsic generation time was estimated to have a mean of 7.12 days (95% CrI 6.27-8.44) for Alpha and of 6.52 days (95% CrI 5.54-8.43) for Delta. The household serial interval was 2.43 days (95% CrI 2.29-2.58) for Alpha and 2.74 days (95% CrI 2.62-2.88) for Delta, and the estimated proportion of pre-symptomatic transmission was 48-51% for both variants. These results indicate limited differences in the incubation period and intrinsic generation time of SARS-CoV-2 variants Alpha and Delta compared to ancestral lineages.
Identifiants
pubmed: 36524247
doi: 10.1017/S0950268822001947
pii: S0950268822001947
pmc: PMC9837419
doi:
Banques de données
figshare
['10.6084/m9.figshare.19802659']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e5Références
JAMA Netw Open. 2022 Aug 1;5(8):e2228008
pubmed: 35994285
Lancet Infect Dis. 2022 May;22(5):603-610
pubmed: 35176230
Epidemiol Infect. 2020 Sep 02;148:e197
pubmed: 32873357
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Science. 2020 May 8;368(6491):
pubmed: 32234805
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13420-13425
pubmed: 27821727
PLoS One. 2022 Oct 10;17(10):e0275667
pubmed: 36215304
Nat Commun. 2018 Jul 19;9(1):2837
pubmed: 30026544
Epidemiol Infect. 2022 Jan 07;:1-9
pubmed: 34991753
J Infect. 2020 Apr;80(4):401-406
pubmed: 32112886
BMJ Open. 2021 May 4;11(5):e042354
pubmed: 33947725
BMC Med. 2020 Aug 7;18(1):226
pubmed: 32762750
Sci Adv. 2017 Feb 17;3(2):e1602024
pubmed: 28232955
J Infect Dis. 2021 Nov 22;224(10):1664-1671
pubmed: 34423821
Euro Surveill. 2020 Apr;25(17):
pubmed: 32372755
Proc Biol Sci. 2007 Feb 22;274(1609):599-604
pubmed: 17476782
Stat Methods Med Res. 2022 Sep;31(9):1686-1703
pubmed: 34931917
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Euro Surveill. 2022 Feb;27(5):
pubmed: 35115077
Nat Commun. 2021 Mar 9;12(1):1533
pubmed: 33750783
Epidemics. 2019 Dec;29:100351
pubmed: 31326355
Elife. 2021 Apr 26;10:
pubmed: 33899740
Lancet Infect Dis. 2020 Jul;20(7):793-802
pubmed: 32247326
Bull World Health Organ. 2022 Feb 01;100(2):161-167
pubmed: 35125541
Proc Biol Sci. 2015 Dec 22;282(1821):20152026
pubmed: 26674948
Epidemics. 2021 Dec;37:100528
pubmed: 34814093
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12680-12685
pubmed: 30463945
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2337-2342
pubmed: 28193880
Lancet Reg Health Eur. 2022 Aug;19:100446
pubmed: 35791373